U.S. could have 300 million extra vaccine doses by end of July; more calls to provide to other nations

Primary tabs

U.S. could have 300 million extra vaccine doses by end of July; more calls to provide to other nations

 

The United States is on track to have gathered an oversupply of hundreds of millions of coronavirus vaccine doses as soon as July, even while many countries in the developing world will have to wait years to vaccinate a majority of their populations, according to a report by the Duke Global Health Innovation Center.

The new estimates, included in the paper alongside recommendations, come as the Biden administration faces mounting pressure to facilitate equitable vaccine distribution around the world. The United States has pledged money to the global immunization effort, but has resisted calls to share vaccine technology or donate surplus doses.

On Thursday, Secretary of State Antony Blinken held a fundraising event for Covax, a World Health Organization-backed push to distribute coronavirus vaccines, particularly to low- and middle-income countries, and called on other nations to do more.

Covax aims to secure and distribute enough vaccine to reach up to 20 percent of the population in 92 participating target countries by the end of 2021. In February, the Biden White House pledged up to $4 billion in support, reversing a Trump administration decision to opt out.

At a virtual event on Thursday, Blinken urged countries to give more, saying an additional $2 billion could help Covax reach 30 percent, rather than 20 percent, of target populations this year. “Just think for a moment of all the people whose lives would be impacted by hitting that higher target.” he said.

The secretary of state said countries must support vaccine manufacturing, but stopped short of announcing any specific policies or plans. He did not address the issue of surplus U.S. doses.

On Wednesday, Oxfam released a letter signed by more than 100 former heads of state and Nobel laureates calling on President Biden to waive intellectual property rules for coronavirus vaccines and “put the collective right to safety for all ahead of the commercial monopolies of the few.”

“Leadership from the US on safe, effective, and equitable global access to Covid-19 vaccines is imperative,” the Duke paper argues, pushing for Washington to increase funding for vaccine-sharing programs, and to donate excess doses and use its clout to open up vaccine manufacturing.

Another proposal, put forward in a letter backed by the Center for Strategic and International Studies (CSIS), calls for the United States to donate 10 percent of its excess doses over the summer, moving to 50 percent by the end of the year, and argues that Biden should deliver a speech this spring to make the case to the American people. ...

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 
Groups this Group Post belongs to: 
Workflow history
Revision ID Field name Date Old state New state name By Comment Operations
No state No state
howdy folks
Page loaded in 0.591 seconds.